Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Precipio Inc (PRPO)

Precipio Inc (PRPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,307
  • Shares Outstanding, K 1,620
  • Annual Sales, $ 18,530 K
  • Annual Income, $ -4,290 K
  • EBIT $ -3 M
  • EBITDA $ -1 M
  • 60-Month Beta 1.14
  • Price/Sales 1.71
  • Price/Cash Flow N/A
  • Price/Book 2.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.40 +17.87%
on 10/17/25
22.28 -13.24%
on 11/04/25
+2.33 (+13.71%)
since 10/14/25
3-Month
13.80 +40.07%
on 08/19/25
22.38 -13.64%
on 09/09/25
+4.62 (+31.41%)
since 08/14/25
52-Week
3.90 +395.64%
on 04/07/25
22.38 -13.64%
on 09/09/25
+12.89 (+200.16%)
since 11/14/24

Most Recent Stories

More News
Precipio Announces its Q3-2025 Financial Results

NEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , filed its 10-Q report today. The following are the highlights of the Company’s...

PRPO : 19.33 (-0.97%)
Precipio Announces Q3-2025 Shareholder Update Call

NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q3-2025 corporate update call on November 17 th , 2025...

PRPO : 19.33 (-0.97%)
Precipio Terminates Its ATM

NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , has terminated its ATM (At-The-Market) instrument with investment bank...

PRPO : 19.33 (-0.97%)
Precipio Announces its Q2-2025 Financial Results

NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , filed its 10-Q report today. The following are the highlights of the...

PRPO : 19.33 (-0.97%)
Precipio Announces Q2-2025 Shareholder Update Call

NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2025 corporate update call on August 14 th , 2025...

PRPO : 19.33 (-0.97%)
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

PRPO : 19.33 (-0.97%)
Arena Group Holdings vs. Precipio: 2 New Top 100 Stocks to Buy. Precipio’s the Buy.

Arena Group Holdings and Precipio entered Barchart’s Top 100 Stocks to Buy on Monday. Both are up more than 100% in 2025. However, when it comes down to making a bet, the latter is the wiser long-term...

AREN : 4.32 (+8.00%)
PRPO : 19.33 (-0.97%)
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

PRPO : 19.33 (-0.97%)
Precipio Announces its Q1-2025 Financial Results

PRPO : 19.33 (-0.97%)
Precipio Announces Q1-2025 Shareholder Update Call

PRPO : 19.33 (-0.97%)

Business Summary

Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class...

See More

Key Turning Points

3rd Resistance Point 21.05
2nd Resistance Point 20.38
1st Resistance Point 19.85
Last Price 19.33
1st Support Level 18.65
2nd Support Level 17.98
3rd Support Level 17.45

See More

52-Week High 22.38
Last Price 19.33
Fibonacci 61.8% 15.32
Fibonacci 50% 13.14
Fibonacci 38.2% 10.96
52-Week Low 3.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar